| The lungs as a portal of entry for systemic drug delivery JS Patton, CS Fishburn, JG Weers Proceedings of the American Thoracic Society 1 (4), 338-344, 2004 | 755 | 2004 |
| Modern aspects of emulsion science F Adams, AS Kabalnov, DN Petsev, T Obey, B Vincent, H Kunieda, ... Royal Society of Chemistry, 2007 | 586 | 2007 |
| Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology DE Geller, J Weers, S Heuerding Journal of aerosol medicine and pulmonary drug delivery 24 (4), 175-182, 2011 | 416 | 2011 |
| Modified-Release Drug Delivery Technology M Rathbone, J Hadgraft, M Roberts, M Lane | 365* | 2008 |
| Effect of the intramolecular charge separation distance on the solution properties of betaines and sulfobetaines JG Weers, JF Rathman, FU Axe, CA Crichlow, LD Foland, DR Scheuing, ... Langmuir 7 (5), 854-867, 1991 | 326 | 1991 |
| Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory A Kabalnov, D Klein, T Pelura, E Schutt, J Weers Ultrasound in medicine & biology 24 (5), 739-749, 1998 | 290 | 1998 |
| Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers MT Newhouse, PH Hirst, SP Duddu, YH Walter, TE Tarara, AR Clark, ... Chest 124 (1), 360-366, 2003 | 268 | 2003 |
| Hollow porous particles in metered dose inhalers LA Dellamary, TE Tarara, DJ Smith, CH Woelk, A Adractas, ML Costello, ... Pharmaceutical research 17, 168-174, 2000 | 266 | 2000 |
| Methods of spray drying pharmaceutical compositions TE Tarara, JG Weers, A Kabalnov, EG Schutt, LA Dellamary US Patent 6,565,885, 2003 | 258 | 2003 |
| Lockout mechanism for aerosol drug delivery devices C Schuler, N Nantel, T Tarara, J Weers US Patent App. 09/852,408, 2002 | 211 | 2002 |
| Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere® powder SP Duddu, SA Sisk, YH Walter, TE Tarara, KR Trimble, AR Clark, ... Pharmaceutical research 19, 689-695, 2002 | 201 | 2002 |
| Stabilized preparations for use in metered dose inhalers JG Weers, EG Schutt, LA Dellamary, TE Tarara, A Kabalnov, ... US Patent 6,309,623, 2001 | 199 | 2001 |
| Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents JG Weers, LA Dellamary, TE Tarara, LA Trevino, HM Ranney US Patent 5,874,481, 1999 | 183 | 1999 |
| Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment A Kabalnov, JA Bradley, S Flaim, D Klein, T Pelura, B Peters, S Otto, ... Ultrasound in medicine & biology 24 (5), 751-760, 1998 | 172 | 1998 |
| Design of fine particles for pulmonary drug delivery JG Weers, TE Tarara, AR Clark Expert opinion on drug delivery 4 (3), 297-313, 2007 | 162 | 2007 |
| Formulation design of dry powders for inhalation JG Weers, DP Miller Journal of pharmaceutical sciences 104 (10), 3259-3288, 2015 | 161 | 2015 |
| Stabilized microbubble compositions EG Schutt, DP Evitts, RA Kinner, CD Anderson, JG Weers US Patent 5,639,443, 1997 | 154 | 1997 |
| Phospholipid-based powders for drug delivery JG Weers, TE Tarara, LA Dellamary, JG Riess, EG Schutt US Patent 9,439,907, 2016 | 147* | 2016 |
| Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract AI Bot, TE Tarara, DJ Smith, SR Bot, CM Woods, JG Weers Pharmaceutical research 17, 275-283, 2000 | 144 | 2000 |
| Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD JE Hastedt, P Bäckman, AR Clark, W Doub, A Hickey, G Hochhaus, ... AAPS open 2, 1-20, 2016 | 139 | 2016 |
Alexey KabalnovretiredVerified email at inkjet3d.com